Skip to main content
. 2019 Jul 3;2019:8512028. doi: 10.1155/2019/8512028

Table 2.

Characteristics of the normal control subjects (NC) or patients with type 2 diabetes (DM), early diabetic kidney disease (DKD1), and late diabetic kidney disease (DKD2) at baseline.

Items NC DM DKD1 DKD2 F P
Gender (male/female) 16/14 16/14 9/6 8/7
Age (year) 61.03 ± 7.95 60.19 ± 9.71 64.70 ± 9.95 62.20 ± 7.85 1.771 0.156
BMI (kg/m2) 23.55 ± 2.59 24.87 ± 3.83 26.14 ± 4.00 23.42 ± 6.29 3.020 0.032
SBP (mmHg) 124 ± 17 128 ± 15 141 ± 14 144 ± 23 9.248 <0.01
DBP (mmHg) 75 ± 12 73 ± 17 77 ± 10 87 ± 14 1.609 0.190
FBG (mmol/L) 4.8 ± 0.5 8.8 ± 2.1 9.1 ± 2.5 10 ± 2.6 41.083 <0.01
HbA1c (%) 5.4 ± 0.4 8.8 ± 2.0 8.5 ± 1.9 7.5 ± 1.2 34.566 <0.01
WBC (109/L) 4.83 ± 0.79 6.46 ± 1.57 7.3 ± 1.56 6.81 ± 1.5 19.205 <0.01
Neu (109/L) 3.03 ± 0.71 4.07 ± 1.25 5.00 ± 1.51 4.74 ± 1.26 16.688 <0.01
Lym (109/L) 1.39 ± 0.25 1.78 ± 0.58 1.61 ± 0.52 1.39 ± 0.52 5.594 <0.01
TG (mmol/L) 1.19 ± 0.35 2.06 ± 1.21 2.41 ± 1.49 2.11 ± 1.32 7.097 <0.01
TC (mmol/L) 4.86 ± 0.74 4.4 ± 1.26 4.97 ± 1.50 4.33 ± 1.06 2.362 0.074
HDL-C (mmol/L) 1.51 ± 0.49 1.21 ± 0.36 1.04 ± 0.26 1.11 ± 0.27 10.173 <0.01
LDL-C (mmol/L) 2.80 ± 0.63 2.94 ± 0.63 3.24 ± 0.78 2.98 ± 0.68 2.553 0.058
Cr (μmol/L) 61.96 ± 9.29 62.65 ± 20.10 101.19 ± 36.50 303.77 ± 79.75 240.383 <0.01
UA (μmol/L) 297.21 ± 69.73 307.38 ± 87.00 368.49 ± 84.69 421.12 ± 90.60 11.670 <0.01
UAER (mmol/L) 5.38 ± 1.08 5.79 ± 2.06 9.09 ± 5.41 14.37 ± 4.98 32.558 <0.01
eGFR (mL/min·1.73 m2) 95.24 ± 14.13 97.91 ± 18.26 61.30 ± 20.49 18.11 ± 7.40 108.749 <0.01

BMI: body mass index, SBP: systolic pressure, DBP: diastolic pressure, FBG: fasting blood glucose, HbA1c: glycosylated hemoglobin A1c, WBC: white blood cell, Neu: neutrophil, Lym: lymphocyte, TG: triglyceride, TC: cholesterol, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, Cr: creatinine, UA: uric acid, eGFR: estimated glomerular filtration rate. The F and P represent the results of comparison between groups.